Fact CheckerSign in

NCT05772325Active, not recruiting

The Effect of Brief Versus Individually Tailored Dietary Advice on Change in Lipids, Blood Pressure, and Diet in Patients With Inflammatory Joint Disease

The Effect of Brief Versus Individually Tailored Dietary Advice on Change in Lipids, Blood Pressure, and Diet in Patients With Inflammatory Joint Disease "The Diet Study"

Source: ClinicalTrials.gov · Last updated 8 Jul 2026

Brief summary (registry, in English)

A randomized controlled study comparing brief dietary intervention with a personal, tailored dietary advice (60 min) on change in LDL-c and change in diet.

Status (registry)
Active, not recruiting
Study type
Interventional
Enrollment
70 (estimated)
First submitted
6 Mar 2023
Start date
20 Feb 2023
Primary completion date
1 Aug 2026
Lead sponsor
Diakonhjemmet Hospital
NCT number
NCT05772325

What you commit to

  • Study type: Interventional
  • Planned participants: 70
  • From 20 Feb 2023 to the primary completion date, 1 Aug 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Recent initiation or change in doses of lipid-lowering therapy or weight loss medication

Other illness

  • Heart failure with systolic EF\<40%
  • Liver failure
  • Mental disorder rendering the patient unable to comply with the protocol

Lab values

  • Kidney failure with GFR \< 35

Other

  • Being able to speak the language of the country
  • Reduced cognitive function
  • Substance abuse

Who the study is looking for

  • Patients with either RA, PsA, or AS, between 30-80 years with an increased risk of future CVD, estimated using the CVD risk calculator. i.e. any risk \> 5 -10 % predicted by Systematic Coronary Risk Evaluation (SCORE2) algorithm. Also, patients with very high risk (predicted risk \>10%) as well as established atherosclerotic CVD (ASCVD) including previous myocardial infarction, coronary intervention (coronary artery bypass grafting or percutaneous coronary intervention), transient ischemic attack/strokes, atherosclerotic diseases of arteries as in the carotid artery or peripheral arterial disease (PAD) will also be included.

Age in the registry: 30 years to 80 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Diakonhjemmet Hospital
Coordinator of this site? Confirm its status
OsloNorwayUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.